© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent

More articles/Ad

More articles/Ad

More articles

  • Burger King India has filed for an IPO that will raise up to Rp4bn ($57m) in primary proceeds as the fast-food chain looks to expand in the country.
  • The IPO of Saudi Aramco has finally arrived, ending years of speculation over whether the world’s most profitable company would be listed. For investors, and equity capital markets as a whole, it ends feverish speculation over the company’s gargantuan valuation and allows funds to start crunching real numbers on potential dividends.
  • Pharmaron Beijing Co, a Chinese pharmaceutical research and development service platform, started testing investor appetite for its IPO on Monday.
  • Shanghai Fosun Pharmaceutical Group, which bought Indian company Gland Pharma in 2016, is planning to list the subsidiary on the National Stock Exchange of India and the BSE.
  • Chinese biopharmaceutical firm 3SBio has taken one step closer to spinning off and listing a unit on Shanghai’s Nasdaq-style Star Market.
  • South Korean defence and information technology firm Hanwha Systems priced its IPO at the bottom of the range on Friday after a poor showing from investors at home and abroad, according to a source close to the deal.